ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II–IV Melanoma Patients and Their Clinicians
Version 2 2024-06-06, 05:21Version 2 2024-06-06, 05:21
Version 1 2023-04-28, 06:36Version 1 2023-04-28, 06:36
journal contribution
posted on 2024-06-06, 05:21 authored by Ann LivingstoneAnn Livingstone, RL MortonASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II–IV Melanoma Patients and Their Clinicians
History
Journal
Annals of Surgical OncologyVolume
27Pagination
585-586Location
Berlin, GermanyISSN
1068-9265eISSN
1534-4681Language
engPublication classification
C4 Letter or noteIssue
2Publisher
SpringerUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC